Clinical Report: Updated Systematic Review on Nebulized Epinephrine for Croup

Overview

This systematic review evaluates the efficacy of nebulized epinephrine in treating pediatric croup. It finds significant short-term improvement in croup severity scores at 30 minutes post-administration, but no statistically significant difference in severity scores at 2 hours and no significant reduction in hospital stay.

Background

Croup is a common pediatric condition characterized by upper airway obstruction, primarily affecting children aged 6 months to 3 years. While hospitalization is rare, effective management is crucial due to the potential for severe respiratory distress. Current treatments include glucocorticoids and nebulized epinephrine, which is recommended for rapid relief of symptoms.

Data Highlights

Key Findings

• Nebulized epinephrine significantly reduced croup severity scores at 30 minutes post-administration.
• The improvement in croup severity was not maintained at 2 hours, with no statistically significant difference between groups.
• The point estimate for hospital stay reduction was -25.1 hours, but did not achieve statistical significance (P = 0.07).
• Current evidence does not support routine use of nebulized epinephrine to shorten hospitalization.

Clinical Implications

Nebulized epinephrine can provide rapid relief for children with moderate-to-severe croup, but its effects are transient.

Conclusion

Nebulized epinephrine offers significant short-term benefits in managing croup, but its role in reducing hospital stay remains uncertain.

Related Resources & Content

1. Frontiers in Pediatrics, 2026 -- Updated Systematic Review on Nebulized Epinephrine for Pediatric Croup Management
2. Canadian Paediatric Society, 2026 -- Acute management of croup in the emergency department
3. American Family Physician, 2026 -- Croup: Rapid Evidence Review
4. MDSpire News — FDA Approves First Needle-Free Epinephrine for Kids
5. MDSpire News — FDA Drops Age Limit for Neffy
6. Frontiers in Pediatrics — Nebulised Chinese herbal medicine for paediatric pneumonia: a meta-analysis
7. JAMA Pediatrics — Valved Holding Chambers in Young Children With Acute Wheezing: A Randomized Clinical Trial
8. FDA Approves First Needle-Free Epinephrine for Kids
9. FDA Drops Age Limit for Neffy
10. Acute management of croup in the emergency department | Canadian Paediatric Society
11. Croup: Rapid Evidence Review | AFP
12. Clinical Practice Guidelines : Croup (Laryngotracheobronchitis)
13. Frontiers | Nebulized Epinephrine for Croup in Children: An Updated Systematic Review